Cisplatin plus capecitabine concomitant with intensity-modulated radiation therapy in non-metastatic anal squamous cell carcinoma: the experience of a single research cancer center

Cisplatin plus capecitabine concomitant with intensity-modulated radiation therapy in non-metastatic anal squamous cell carcinoma: the experience of a single research cancer center

Background and Aims: The standard treatment of non-metastatic anal squamous cell carcinoma (ASCC) consists of chemotherapy with mitomycin (MMC) plus 5-fluorouracil (5FU) for 1–2 cycles concomitant with pelvic radiotherapy. Subsequent studies introduced cisplatin (CDDP) combined with 5FU, with unclea...

Full description

Bibliographic Details
Main Authors: Maria Saveria Rotundo, Maria Giulia Zampino, Paola Simona Ravenda, Vincenzo Bagnardi, Giulia Peveri, Veronica Dell’Acqua, Alessia Surgo, Cristina Trovato, Luca Bottiglieri, Emilio Bertani, Wanda Luisa Petz, Uberto Fumagalli Romario, Nicola Fazio
Format: Article
Language:English
Published: SAGE Publishing 2020-07-01
Series:Therapeutic Advances in Medical Oncology
Online Access:https://doi.org/10.1177/1758835920940945

Internet

https://doi.org/10.1177/1758835920940945

Similar Items